Forward P/S Multiple: Senseonics Holdings, Inc. (SENS)

Senseonics Holdings - graphic logo of issuer SENS

Geopolitical conflicts and logistics disruptions are hindering the global growth of Senseonics Holdings (SENS), as illustrated by the base chart from the GURU.Markets service. The forward price-to-sales ratio shows that the value of 9.60 expresses the metric level. Demand for Eversense implantable sensors is elastic, yet the company maintains moderate pricing power. Patent protection and strict FDA requirements create a formidable barrier to entry for new players.

Senseonics - SENS Market Cap to Projected Revenue (period 07/04/2022 - 11/16/2026)

Summary analytical data breakdowns for Senseonics Holdings (SENS)

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Fundamental company analysis:SENS (Senseonics Holdings Inc)
Product sample of Eversense

Portfolio managers evaluate the operating model of Senseonics Holdings (SENS) through the ratio of current market capitalization to projected annual revenue, which determines the cost of one dollar of future sales. By analyzing the modeled P/S of Senseonics Holdings (SENS), an investor can discern the extent of the asset's overvaluation, which is critical as Senseonics Holdings (SENS) aggressively competes with CGM market behemoths for consumer market share amid pricing pressure.

Who Senseonics Holdings competes with

Price-to-Projected Revenue Ratio Dexcom CGM DXCM|Penumbra Corp (PEN) - Market Cap to Future Revenue Ratio|Novanta Inc - Forward P/S Multiple|HAE (Haemonetics Corporation) - Market Cap to Projected Revenue|INSP: Forward P/S Multiple|Market Cap to Projected Revenue PRCT|CNMD (CONMED Inc.) - Forward P/S Multiple|Pulse Corp (PLSE) - Market Cap to Expected Sales Ratio|Forward P/S Multiple INMD|Forward P/S Multiple picardmedical.com (PMI)|Forward P/S Multiple SRDX (surmodics.com)|Forward P/S Multiple NeuroPace Inc NPCE|TCMD - Price-to-Projected Revenue Ratio|SNWV: Price-to-Projected Revenue Ratio|Outset Medical Corp (OM) - Price-to-Projected Revenue Ratio|SmartVest - Forward Price to Sales|LNSR (LENSAR Inc) - Forward P/S Multiple|Market Cap to Future Revenue Ratio AVITA Medical Inc. RCEL|Price-to-Projected Revenue Ratio Profound Medical (PROF)|Baird Medical Corp (BDMD) - Projected Price to Revenue|EDAP TMS SA - Forward Price-to-Revenue Multiple|Forward P/S Multiple Bovie Medical APYX|IceCure Medical Ltd. - Forward P/S Multiple|Market Cap to Expected Sales Ratio Pulmonx LUNG|TELA Bio (TELA) - Price-to-Projected Revenue Ratio|Future Price to Revenue CTSO (CytoSorbents Corp.)|Price-to-Projected Revenue Ratio sensushealthcare.com|Forward Price-to-Revenue Multiple Zynex, Inc. (ZYXI)|Forward P/S Multiple ECOR|RBOT - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio inspira-technologies.com IINN|Price to Expected Revenue Ratio ICU (SeaStar Medical Holding Corp.)|IRIX: Forward Price-to-Revenue Multiple|ibs.inc - Price to Expected Revenue Ratio|XAIR: Forward P/S Multiple|Future Price to Revenue PFSA (Profusa Inc.)|Forward Price-to-Revenue Multiple SSKN|Price-to-Projected Revenue Ratio GCTK|Price-to-Projected Revenue Ratio NanoVibronix (NAOV)|Venus Concept - Market Cap to Projected Revenue|Forward P/S Multiple NUWE (Nuwellis Corp)|Forward Price to Sales AEMD|ASXC - Price-to-Projected Revenue Ratio|Projected Price to Revenue Avinger, Inc (AVGR)|BSGM: Forward P/S Multiple|Cutera (CUTR) - Forward P/S Multiple|KNW (Know Labs) - Forward P/S Multiple|Forward Price-to-Revenue Multiple Inari Medical (NARI)|Price-to-Projected Revenue Ratio nevro.com (NVRO)|RSLS (ReShape Lifesciences, Inc.) - Forward Price to Sales|Forward P/S Multiple SILK (Silk Road Medical)